Researchers set sights on new era in neuroprotection
Monday, October 15, 2012 - 19:00
in Health & Medicine
A research team has identified a set of experimental drugs called LRRK2 inhibitors that may go beyond symptom relief to directly counter the inflammation and nerve cell death at the root of Parkinson's disease. At least, these effects have been suggested in mouse and cell culture studies meant to approximate human disease.